Therapeutic agents for Alzheimer’s disease: a critical appraisal
Marta Weinstock · 2024
Read Therapeutic agents for Alzheimer’s disease: a critical appraisal by Marta Weinstock (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11663918.txt.
Description
Marta Weinstock gives a critical review of drugs for Alzheimer's disease, the most common cause of dementia. Faulty amyloid protein sits at the center of the inherited form, which led to antibody drugs against it. Two won approval in the United States, but gains were small and side effects can be serious.
She notes that cell damage from oxygen stress and raised inflammatory signals appear in all patients and track memory loss well. Some drugs for other ills ease thinking but cannot enter the brain safely. She ends with a compound she favors, which calmed these processes and slowed memory decline in a mid-stage trial, with no more side effects than a dummy pill.
Catalog record
| CREATOR | Marta Weinstock |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |